Want to see TSE:OILS full AI Analyst Report?
Top Page
Nextleaf Solutions
(OILS)
Select Model
Select Model
Rating:47Neutral
Price Target:
C$0.02
▼(-50.00% Downside)
Action:Reiterated
Date:10/21/26
The score is held down primarily by weak TTM profitability (including negative gross profit) and bearish technical signals (price below all major moving averages with negative MACD). A relatively stable balance sheet with low leverage and improved positive free cash flow partially offset these risks, but the negative P/E and lack of dividend reflect ongoing earnings pressure.
Positive Factors
Low Leverage
Manageable leverage and positive equity provide financial flexibility while reducing pressure from debt servicing. This gives Nextleaf more capacity to withstand operating volatility and support investment in processing capabilities, although current losses limit the benefit of that flexibility.
Negative Factors
Revenue Decline
Falling revenue signals weaker recent commercial performance and reduces operating leverage across the processing platform. Unless demand or customer activity improves, lower sales can make fixed costs harder to absorb and constrain the company’s ability to build durable scale.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Manageable leverage and positive equity provide financial flexibility while reducing pressure from debt servicing. This gives Nextleaf more capacity to withstand operating volatility and support investment in processing capabilities, although current losses limit the benefit of that flexibility.
Read all positive factors
Nextleaf Solutions (OILS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$3.40M
Dividend YieldN/A
Average Volume (3M)101.71K
Price to Earnings (P/E)―
Beta (1Y)1.65
Revenue Growth-18.30%
EPS Growth-397.37%
CountryCA
Employees26
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.01
Shares Outstanding170,208,710
10 Day Avg. Volume165,795
30 Day Avg. Volume101,711
Financial Highlights & Ratios
PEG Ratio0.79
Price to Book (P/B)2.55
Price to Sales (P/S)1.04
P/FCF Ratio33.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nextleaf Solutions Business Overview & Revenue Model
Company Description
Nextleaf Solutions Ltd. operates as a cannabis extraction technology enterprise, pioneering and licensing advanced methods for the processing, refinement, and development of cannabinoid formulations throughout Canada. The company is actively invol...
How the Company Makes Money
Nextleaf Solutions makes money primarily through B2B cannabis processing and ingredient sales within regulated markets. Key revenue streams include: (1) selling bulk cannabinoid ingredients (e.g., refined cannabis oils/distillates) to licensed can...
Nextleaf Solutions Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
66
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.90M | 11.26M | 12.48M | 8.18M | 4.41M | 3.38M |
| Gross Profit | -400.34K | 1.94M | 3.74M | 2.31M | 661.24K | -855.03K |
| EBITDA | -1.42M | 611.70K | -749.47K | 1.11M | -1.94M | -3.79M |
| Net Income | -1.92M | -162.94K | -1.44M | 223.33K | -3.49M | -5.39M |
Balance Sheet | ||||||
| Total Assets | 7.74M | 7.82M | 8.57M | 8.54M | 7.15M | 9.19M |
| Cash, Cash Equivalents and Short-Term Investments | 92.08K | 446.56K | 438.54K | 898.90K | 377.72K | 915.38K |
| Total Debt | 394.74K | 793.82K | 384.69K | 489.75K | 1.36M | 3.25M |
| Total Liabilities | 3.95M | 3.25M | 4.06M | 4.40M | 4.14M | 5.77M |
| Stockholders Equity | 3.78M | 4.57M | 4.50M | 4.13M | 3.02M | 3.43M |
Cash Flow | ||||||
| Free Cash Flow | 246.84K | 353.16K | -682.48K | 851.89K | -911.02K | -2.94M |
| Operating Cash Flow | 327.56K | 414.88K | -614.09K | 875.46K | -802.19K | -2.87M |
| Investing Cash Flow | -303.69K | -267.79K | -68.39K | -23.56K | -108.83K | -21.48K |
| Financing Cash Flow | -175.00K | -139.06K | 222.12K | -330.71K | 373.35K | 2.82M |
Nextleaf Solutions Technical Analysis
Negative
0.04
Price Trends
0.03
Negative
0.04
Negative
0.05
Negative
Market Momentum
>-0.01
Negative
37.19
Neutral
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OILS, the sentiment is Negative. The current price of 0.04 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.03, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 37.19 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:OILS.
Nextleaf Solutions Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | C$198.55M | 17.69 | 9.45% | ― | 14.66% | -33.72% | |
61 Neutral | C$186.13M | 2.05 | 21.99% | ― | 38.14% | 2030.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | C$27.77M | -5.60 | -13.79% | ― | -6.74% | 43.54% | |
47 Neutral | C$3.40M | -1.75 | -43.92% | ― | -18.30% | -397.37% | |
42 Neutral | C$41.96M | -0.76 | -2099.75% | ― | -100.00% | 94.43% |
* Healthcare Sector Average
TSE:OILS
Nextleaf Solutions
0.02
-0.04
-66.67%
TSE:ATLE
Willow Biosciences Inc
0.09
-0.07
-41.94%
TSE:OGI
Organigram Global
1.32
-0.95
-41.85%
TSE:LABS
MediPharm Labs
0.07
>-0.01
-13.33%
TSE:LOVE
Cannara Biotech
2.01
0.30
17.54%
TSE:HASH
Simply Solventless Concentrates Ltd
0.05
-0.19
-80.43%
Nextleaf Solutions Corporate Events
Business Operations and StrategyExecutive/Board Changes
Nextleaf Solutions Launches Strategic Review as CFO Sam Kassem Steps In as Interim CEO
Neutral
Sep 16, 2026
Innovation-driven cannabis processor Nextleaf Solutions has announced a leadership change as Chief Executive Officer, President and director Emma Andrews steps down after eight years with the company. Andrews, who helped transform Nextleaf into a ...
Business Operations and StrategyFinancial Disclosures
Nextleaf Narrows Loss as Glacial Gold Strengthens Market Position
Positive
Sep 3, 2026
Nextleaf Solutions reported fiscal third-quarter 2026 results showing modest sequential revenue growth and a sharply reduced net loss, aided by a product mix shift that cut excise taxes by nearly a third. Net revenue rose 5% to about $2.53 million...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.